When is the right time to cash out of AbbVie Inc. [ABBV] stock?
In yesterday’s Wall Street session, AbbVie Inc. (NYSE:ABBV) shares traded at $151.55, down -0.37% from the previous session. As of this writing, 29 analysts cover AbbVie Inc. (NYSE:ABBV). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $205.00 and a low of […]
Stocks of AbbVie Inc. [ABBV] are gaining investors’ attention: here’s why
In yesterday’s Wall Street session, AbbVie Inc. (NYSE:ABBV) shares traded at $151.44, up 0.44% from the previous session. As of this writing, 30 analysts cover AbbVie Inc. (NYSE:ABBV). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $205.00 and a low of […]
AbbVie Inc. (NYSE:ABBV): A Fundamentally Weighted Stock for Long-Term Investors
The stock of AbbVie Inc. (NYSE:ABBV) last traded at $137.68, up 0.81% from the previous session. ABBV stock price is now -0.70% away from the 50-day moving average and -8.21% away from the 200-day moving average. The market capitalization of the company currently stands at $238.59B. With the price target of $167, HSBC Securities recently […]
